Cheil Bio Co

Cheil Bio Co Deferred Tax Liabilities

Delisted·Feb 25, 2026

The Deferred Tax Liabilities of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 147.51 M KRW. In the previous year, Deferred Tax Liabilities was 148.22 M KRW — a change of -0.48% (lower).

Deferred Tax Liabilities

147.51 MKRW

YoY

-0.48%

Last updated:

Deferred Tax Liabilities of Cheil Bio Co is 2023 147.51 M KRW. Deferred Tax Liabilities of Cheil Bio Co was 2022 148.22 M KRW. It decreases by -0.48% lower compared to the previous year.

The Cheil Bio Co Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2014
86.00 M KRW
Jan 1, 2015
98.00 M KRW
Jan 1, 2016
38.00 M KRW
Jan 1, 2021
155.27 M KRW
Jan 1, 2022
148.22 M KRW
Jan 1, 2023
147.51 M KRW
The Cheil Bio Co Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
147.51 MKRW-0.48%
148.22 MKRW-4.55%
155.27 MKRW+308.62%
38.00 MKRW-61.22%
98.00 MKRW+13.95%
86.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Deferred Tax Liabilities of Cheil Bio Co is 147.51 M KRW in 2023.

Deferred Tax Liabilities of Cheil Bio Co changed from 148.22 M KRW to 147.51 M KRW, representing a -0.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cheil Bio Co

All Key Metrics — Cheil Bio Co